Search Count: 6
 |
Crystal Structure Of The Catalytic Domain Of Mmp-13 Complexed With N-Phenyl-4-((4H-1,2,4-Triazol-3-Ylsulfanyl)Methyl)-1,3-Thiazol-2-Amine
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.20 Å Release Date: 2017-01-18 Classification: HYDROLASE/HYDROLASE INHIBITOR Ligands: ZN, CA, NA, EDO, WMM |
 |
Crystal Structure Of The Catalytic Domain Of Mmp-13 Complexed With 4-Oxo-N-(3-(2-(1H-1,2,4-Triazol-3-Ylsulfanyl)Ethoxy)Benzyl)-3,4-Dihydroquinazoline-2-Carboxamide
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.60 Å Release Date: 2017-01-18 Classification: HYDROLASE/HYDROLASE INHIBITOR Ligands: ZN, CA, WNN |
 |
Structure Of Protein Kinase C Theta With Compound 10: 2,2-Dimethyl-7-(2-Oxidanylidene-3~{H}-Imidazo[4,5-B]Pyridin-1-Yl)-1-(Phenylmethyl)-3~{H}-Quinazolin-4-One
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:2.00 Å Release Date: 2016-05-11 Classification: TRANSFERASE/TRANSFERASE INHIBITOR Ligands: 5VS |
 |
Crystal Structure Of The Catalytic Domain Of Mmp-13 Complexed With 4-(2-((6-Fluoro-2-((3-Methoxybenzyl)Carbamoyl)-4-Oxo-3,4-Dihydroquinazolin-5-Yl)Oxy)Ethyl)Benzoic Acid
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.98 Å Release Date: 2015-05-20 Classification: HYDROLASE/HYDROLASE INHIBITOR Ligands: ZN, CA, NA, FMT, WHH |
 |
Crystal Structure Of The Catalytic Domain Of Mmp-13 Complexed With N-(3-Methoxybenzyl)-4-Oxo-3,4-Dihydroquinazoline-2-Carboxamide
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:2.30 Å Release Date: 2014-09-24 Classification: HYDROLASE/HYDROLASE INHIBITOR Ligands: ZN, CA, NA, WGG |
 |
Crystal Structure Of The Catalytic Domain Of Mmp-13 Complexed With N-(3-Methoxybenzyl)-4-Oxo-3,4-Dihydrothieno[2,3-D]Pyrimidine-2-Carboxamide
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.60 Å Release Date: 2014-09-24 Classification: HYDROLASE/HYDROLASE INHIBITOR Ligands: ZN, CA, NA, FMT, EDO, WLL |